Supporting Women’s Lifelong Physical, Mental, and Social Well-being

Japan Bio Products Co., Ltd. (“JBP”) is proud to announce its sponsorship of the “Women’s Support & Well-being AWARD 2025,” organized by the Japan Women’s Foundation, starting in 2025. This award, hosted by the Japan Women’s Foundation, which is dedicated to supporting women’s lifelong physical, mental, and social well-being, recognizes individuals and organizations in Japan who are making outstanding contributions to women’s empowerment from a comprehensive perspective. By supporting this award, JBP aims to contribute to the promotion of women’s lifelong well-being through the activities of the Japan Women’s Foundation.

At the award ceremony held on August 20, 2025, the Grand Prize and Activity Awards were presented to women and organizations that contributed to society by supporting the next generation of women in achieving both physical and mental health as well as social success in 2024. In addition to its sponsorship, JBP provided a special prize, offering its cosmetic brand “LNC Placental Skincare White Series.”

Commemorative photo (from left): Mr. Lim,Hong Seok, President & CEO of JBP; Dr. Ruriko Tsushima, Chairperson of the Japan Women’s Foundation; Ms. Keiko Sasao, Director of the Foundation; and Mr. Katsumasa Tashiro, COO of RE Biotech, JBP.

Japan Bio Products is a pharmaceutical company that manufactures and markets “Laennec,” a medicine derived from human placentas provided by obstetrics and gynecology clinics. Guided by the concept of “the ideal cycle and preservation of life and environment through placentas,” the company engages in various activities that contribute to society. Supported by many people involved in pregnancy and childbirth, JBP’s initiatives aim to realize a life-cycle-oriented society through placentas, which formed the foundation for its sponsorship of this award.

JBP’s in-house bio-venture, RE Biotech, is conducting research and development on next-generation products, including practical applications of placenta-based implantation enhancers, aiming to advance infertility treatment and create a society in which women can thrive more easily.

As a pharmaceutical company handling placenta-derived products, Japan Bio Products remains committed to fulfilling its social responsibility and will continue to support women’s lifelong physical, mental, and social well-being in collaboration with the Japan Women’s Foundation.

Japan Women’s Foundation (General Incorporated Foundation)　（https://japan-women-foundation.org/）
Japan Bio Products Co., Ltd. (“JBP”)（https://jbp.placenta.co.jp/）
RE Biotech.（https://rebiotech.co.jp/）